ARHGAP9
Basic information
Region (hg38): 12:57472264-57488814
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 21 | 12 | 36 | |||
Total | 0 | 0 | 45 | 14 | 4 |
Variants in ARHGAP9
This is a list of pathogenic ClinVar variants found in the ARHGAP9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-57472521-G-C | not specified | Uncertain significance (Mar 17, 2023) | ||
12-57472609-C-G | not specified | Uncertain significance (Jan 07, 2022) | ||
12-57472614-C-T | not specified | Uncertain significance (May 09, 2023) | ||
12-57472623-G-T | not specified | Uncertain significance (Jun 04, 2024) | ||
12-57473639-T-C | not specified | Likely benign (Feb 23, 2023) | ||
12-57473677-C-G | not specified | Uncertain significance (Jun 06, 2023) | ||
12-57474125-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
12-57474143-T-C | not specified | Uncertain significance (Jun 19, 2024) | ||
12-57474680-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
12-57474683-A-T | not specified | Uncertain significance (May 31, 2022) | ||
12-57475365-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
12-57475386-T-G | not specified | Uncertain significance (Oct 05, 2021) | ||
12-57475389-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
12-57476106-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
12-57476145-C-T | not specified | Uncertain significance (Jun 13, 2024) | ||
12-57476351-C-G | not specified | Likely benign (Jan 02, 2024) | ||
12-57476372-A-C | Coronary artery spasm 3, susceptibility to | Uncertain significance (Jan 01, 2010) | ||
12-57476398-C-A | not specified | Uncertain significance (Dec 02, 2024) | ||
12-57476450-T-C | not specified | Uncertain significance (Sep 14, 2023) | ||
12-57476616-C-A | not specified | Uncertain significance (Jun 01, 2023) | ||
12-57476621-T-A | not specified | Uncertain significance (Jan 31, 2023) | ||
12-57476638-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
12-57476893-G-C | not specified | Uncertain significance (May 31, 2023) | ||
12-57477182-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
12-57477262-C-T | not specified | Uncertain significance (Aug 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGAP9 | protein_coding | protein_coding | ENST00000393791 | 17 | 16560 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.94e-11 | 0.983 | 125629 | 0 | 119 | 125748 | 0.000473 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.414 | 414 | 438 | 0.944 | 0.0000257 | 4633 |
Missense in Polyphen | 141 | 184.03 | 0.76617 | 1944 | ||
Synonymous | 1.05 | 162 | 180 | 0.900 | 0.00000982 | 1577 |
Loss of Function | 2.37 | 23 | 39.0 | 0.590 | 0.00000199 | 411 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00146 | 0.00143 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.000763 | 0.000761 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000525 | 0.000519 |
Middle Eastern | 0.000763 | 0.000761 |
South Asian | 0.000231 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has a substantial GAP activity toward CDC42 and RAC1 and less toward RHOA. Has a role in regulating adhesion of hematopoietic cells to the extracellular matrix. Binds phosphoinositides, and has the highest affinity for phosphatidylinositol 3,4,5-trisphosphate, followed by phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:11396949}.;
- Pathway
- Neutrophil degranulation;Signal Transduction;Innate Immune System;Immune System;Rho GTPase cycle;Signaling by Rho GTPases;Regulation of RAC1 activity;Regulation of RhoA activity
(Consensus)
Recessive Scores
- pRec
- 0.213
Intolerance Scores
- loftool
- 0.930
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.9
Haploinsufficiency Scores
- pHI
- 0.141
- hipred
- N
- hipred_score
- 0.179
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.356
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arhgap9
- Phenotype
Gene ontology
- Biological process
- signal transduction;regulation of GTPase activity;neutrophil degranulation;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction
- Cellular component
- extracellular region;cytoplasm;cytosol;secretory granule lumen
- Molecular function
- GTPase activator activity;protein binding;phosphatidylinositol-3,4,5-trisphosphate binding